HomeVFY • ASX
add
Vitrafy Life Sciences Ltd
Previous close
$1.72
Year range
$1.08 - $1.95
Market cap
85.91M AUD
Avg Volume
44.06K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 991.52K | 188.36% |
Operating expense | 2.19M | -12.34% |
Net income | -3.56M | 72.26% |
Net profit margin | -359.27 | 90.38% |
Earnings per share | — | — |
EBITDA | -3.74M | -10.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.80M | -33.82% |
Total assets | 23.68M | -34.19% |
Total liabilities | 2.03M | 58.97% |
Total equity | 21.65M | — |
Shares outstanding | 63.85M | — |
Price to book | 5.06 | — |
Return on assets | -39.63% | — |
Return on capital | -42.66% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.56M | 72.26% |
Cash from operations | -3.33M | -65.60% |
Cash from investing | 691.00 | 100.01% |
Cash from financing | -21.95K | -100.14% |
Net change in cash | -3.40M | -184.56% |
Free cash flow | -2.27M | 37.51% |
About
Founded
2017
Website
Employees
22
